Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
f-627 (7 trials)
filgrastim (neupogen) (2 trials)
cyclophosphamide (cytoxan) (3 trials)
docetaxel (taxotere) (1 trial)
doxorubicin (Doxil) (1 trial)
epirubicin (ellence) (2 trials)
f-652 (1 trial)
interleukin-22 igg2-fc (1 trial)
prednisone (meticorten) (1 trial)
sargramostim (leukine) (1 trial)
A-319 (1 trial)
Breast Neoplasms (Phase 3)
Graft vs Host Disease (Phase 2)
Lymphoma (Phase 1)
Lymphoma, B-Cell (Phase 1)
Neutropenia (Phase 3)
Trials (10 total)
Trial APIs (11 total)